stroke

Study: Rare type of stroke may be increasing in pregnant womenPreliminary data from a retrospective study suggest that incidence of spontaneous subarachnoid hemorrhage (sSAH) may be increasing among pregnant women. Plus: Study finds lower risk of diabetes a benefit of breastfeeding. Also: Taking prenatal folic acid and multivitamins lowers the risk of autism, according to results of a new case-control study.
Three ways healthcare executives can uncover consumers at risk for fluWith influenza activity increasing sharply, here’s how healthcare executives can determine which health plan members are at risk for the flu.
New high blood pressure guideline healthcare cost impactFifty percent of Americans have high blood pressure, per new guidelines. Here’s how those guidelines could affect medication utilization and healthcare spending.
No insurance is growing problem for heart patients, providersTwo new studies address the financial implications of unexpected major healthcare expenses for common cardiovascular conditions and procedures.
Do antidepressants take more lives than they save?An eye-opening Canadian study has surprising findings about the risk of death and antidepressants.
Impact of aspirin in reducing preterm preeclampsiaA study looks at the efficacy of aspirin in reducing preterm preeclampsia. Plus: The CDC reports on antidepressant use in the United States. Also, a look at whether vaginal estrogen postmenopause increases the risk of heart disease and certain types of cancer.
Blockbuster diabetes drug earns heart indication
Blockbuster diabetes drug earns heart indicationA top-selling diabetes drug has gained a cardiovascular indication from FDA.
Migraines in Women
Migraines in WomenThis article reviews how migraines in women are impacted by the fluctuating hormone levels they experience throughout their lifecycle.
Shingles associated with increased risk of stroke, heart attackPatients who have a history of herpes zoster may have an increased risk of heart attack or stroke, according to findings published in a research letter.
Game-changing cholesterol-buster further reduces heart attack, strokeA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%.